Expression of CD69 on T‐cell subsets in HIV‐1 disease

References

• Hazenberg M. D., Hamann D., Schuitemaker H., Miedema F. T cell depletion in HIV‐1 infection: how CD4+ T cells go out of stock. Nature Immunol 2000; 1: 285–9
   PubMed Web of Science ®Google Scholar
• Mahalingam M., Peakman D., Davies E. T., Pozniak A., McManus T. J., Vergani D. T cell activation and disease severity in HIV infection. Clin Exp Immunol 1993; 93: 337–43
   PubMedGoogle Scholar
• Meyaard L., Otto S. A., Jonker R. R., Mijnster M. J., Keet R. P., Miedema F. Programmed death of T cells in HIV‐1 infection. Science 1992; 257: 217–19
   PubMed Web of Science ®Google Scholar
• Santis A. G., Campanero M. R., Alonso J. L., Tugores A., Alonso M. S., Yague E., et al. Tumor necrosis factor‐α production induced in T lymphocytes through the AIM/CD69 activation pathway. Eur J Immunol 1992; 22: 1253–9
   PubMed Web of Science ®Google Scholar
• Lopez‐Cabrera M., Santis A. G., Fernandez‐Ruiz E., Blacher R., Esch F., Sanchez‐Madrid F. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C‐type animal lectin superfamily of signal‐transmitting receptors. J Exp Med 1993; 178: 537–47
   PubMed Web of Science ®Google Scholar
• Testi R., Philips J. H., Lanier L. L. T cell activation via Leu‐23 (CD69). J Immunol 1989; 143: 1123–8
   PubMed Web of Science ®Google Scholar
• Vandenberghe P., Verwilghen J., van Vaeck F., Ceuppens J. L. Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium‐ and tyrosine kinase‐dependent mechanism. Immunology 1993; 78: 210–17
   PubMedGoogle Scholar
• Hara T., Jung L. K., Bjorndahl J. M., Fu S. M. Human T cell activation II. Rapid induction of a phosphorylated 28Kd/32Kd disulfide‐linked early activation antigen (EA 1) by 12‐o‐tetradecanoyl phorbol‐13‐acetate, mitogens, and antigens. J Exp Med 1986; 164: 1988–2005
   PubMed Web of Science ®Google Scholar
• Krowka J. F., Cuervas B., Maron D. C., Steimer K. S., Ascher M. S., Sheppard H. W. Expression of CD69 after in vitro stimulation: a rapid method for quantitating impaired lymphocyte responses in HIV‐infected individuals. Aq Im Def Syndr Hum Retr 1996; 11: 95–104
   PubMedGoogle Scholar
• Caruso A., Licenziati M., Corulli A. D., Canaris A. D., De Francesco M. A., Fiorentini S., et al. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry 1997; 27: 71–6
   PubMedGoogle Scholar
• Maino V. C., Suni M. A., Ruiteberg J. J. Rapid flow cytometry method for measuring lymphocyte subset activation. Cytometry 1995; 20: 127–33
   PubMedGoogle Scholar
• Sanchez‐Mateos P., Sanchez‐Madrid F. Structure‐function relationship and immunochemical mapping of external and intracellular antigenic sites on the lymphocyte activation inducer molecule, AIM/CD69. Eur J Immunol 1991; 21: 2317–25
   PubMedGoogle Scholar
• Sancho D., Gómez M., Sánchez‐Madrid F. CD69 is an immunoregulatory molecule induced following activation. Trents Immunol 2005; 26: 136–40
   PubMed Web of Science ®Google Scholar
• Krummel M. F., Allison J. P. CTLA‐4 engagement inhibits IL‐2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 1996; 183: 2533–40
   PubMed Web of Science ®Google Scholar
• Choremi‐Papadopoulou E., Panagiotou N., Samouilidou E., Kontopidou F., Viglis V., Antoniadou A., et al. CD28 costimulation and CD28 expression in T lymphocyte subsets in HIV‐1 infection with and without progression to AIDS. Clin Exp Immunol 2000; 119: 499–506
   PubMedGoogle Scholar
• Choremi‐Papadopoulou H., Viglis V., Gargalianos P., Kordossis T., Iniotaki‐Theodoraki A., Kosmidis J. Dowregulation of CD28 surface antigen on CD4+ and CD8+ T lymphocytes during HIV‐1 infection. J Acq Imm Def Syndr 1994; 7: 245–3
   PubMed Web of Science ®Google Scholar
• DeMartino M., Rossi M. E., Azzari C., Gelli M. G., Chiarelli F., Galli L., Vierucci A. Viral load and CD69 molecule expression on freshly isolated and cultured mitogen‐stimulated lymphocytes of children with perinatal HIV‐infection. Clin Exp Immunol 1999; 117: 513–16
   PubMedGoogle Scholar
• Nielsen S. D., Afzelius P., Ersbøll A. K., Nielsen J. O., Hansen J. E. S. Expression of the activation antigen CD69 predicts functionality of the in vitro expanded peripheral blood mononuclear cells (PBMC) from healthy donors and HIV‐infected patients. Clin Exp Immunol 1998; 114: 66–72
   PubMed Web of Science ®Google Scholar
• Bocchieri M. H., Talle M. A., Maltese L. M., Ragucci I. R., Hwang C. C., Goldstein G. Whole blood culture for measuring mitogen induced T cell proliferation provides superior correlations with disease state and T cell phenotype in asymptomatic HIV‐infected subjects. J Immunol Methods 1995; 26: 233–43
   Google Scholar
• Maecker H. T., Rinfret A., D'Souza P., Darden J., Roig E., Landry C., et al. Standardization of cytokine flow cytometry assays. BMC Immunol 2005; 6: 13
   PubMed Web of Science ®Google Scholar
• Prince H. E., Lapé‐Nixon M. CD69 expression reliably predicts the anti‐CD3‐induced proliferative response of lymphocytes from human immunodeficiency virus type‐1‐infected patients. Clin Diagn Lab Immunol 1997; 4: 217–22
   PubMedGoogle Scholar
• Mardiney M., Brown M. R., Fleischer T. A. Measurement of T cell CD69 expression. A rapid and efficient means to assess mitogen‐ or antigen‐induced proliferative capacity in normals. Cytometry 1996; 26: 305–10
   PubMedGoogle Scholar
• Lim L. C. L., Fiordalisi M. N., Mantell J. L., Schmitz J. L., Folds J. D. A whole‐blood assay for qualitative and semiquantitative measurements of CD69 surface expression on CD4 and CD8 T lymphocytes using flow cytometry. Clin Diagn Lab Immunol 1998; 5: 392–8
   PubMedGoogle Scholar
• Roos M. T., Miedema F., Meinesz A. P., De Leeuw N. A., Pakker N. G., Lange J. M., et al. Low T cell reactivity to combined CD3 plus CD28 stimulation is predictive for progression to AIDS: correlation with decreased CD28 expression. Clin Exp Immunol 1996; 105: 409–15
   PubMedGoogle Scholar
• Roos M. T., Prins M., Koot M., De Wolf F., Bakker M., Coutinho R. A., et al. Low T‐cell responses to CD3 plus CD28 monoclonal antibodies are predictive of development of AIDS. AIDS 1998; 12: 1745–51
   PubMedGoogle Scholar
• Sieg S. F., Harding C. V., Lederman M. M. HIV‐1 infection impairs cell cycle progression of CD4+ T cells without affecting early activation responses. J Clin Invest 2001; 108: 757–64
   PubMedGoogle Scholar
• Hickey T. E., Blair P. J., Perfetto S., Smoot D. S., Wagner K. F., St Louis D. C., et al. Intact antigen receptor‐mediated calcium signals in patients with early stage HIV‐1 infection. J Immunol 1996; 156: 4012–17
   PubMedGoogle Scholar
• Schwartz R. H. Costimulation of T lymphocytes. The role of CD28, CTLA‐4, and B7/BB1 in interleukin‐2 production and immunotherapy. Cell 1992; 71: 1065–68
   PubMed Web of Science ®Google Scholar
• Ostrowski S. R., Gerstoft J., Pedersen B. K., Ullum H. A low level of CD4+CD28+ T cells is an independent predictor of high mortality in human immunodeficiency virus type 1‐infected patients. J Infect Dis 2003; 187: 1726–34
   PubMedGoogle Scholar
• McCloskey T. W., Haridas V., Pontrelli L., Pahwa S. Response to superantigen stimulation in peripheral blood mononuclear cells from children perinatally infected with human immunodeficiency virus and receiving highly active antiretroviral therapy. Clin Diagn Lab Immunol 2004; 11: 957–62
   PubMedGoogle Scholar
• Sieg S. F., Bazdar D. A., Harding C. V., Lederman M. M. Differential expression of interleukin‐2 and gamma interferon in human immunodeficiency virus disease. J Virol 2001; 75: 9983–5
   PubMedGoogle Scholar
• Kebba A., Kaleebu P., Serwanga J., Rowland S., Yirrell D., Downing R., et al. HIV Type 1 antigen‐responsive CD4+ T‐lymphocytes in exposed yet HIV type 1 seronegative Ugandans. AIDS Res Hum Retroviruses 2004; 20: 67–75
   PubMed Web of Science ®Google Scholar
• Kapogiannis B. G., Henderson S. L., Nigam P., Sharma S., Chennareddi L., Herndon J. G., et al. Defective IL‐2 production by HIV‐1‐specific CD4 and CD8 T cells in an adolescent/young adult cohort. AIDS Res Hum Retrov 2006; 22: 272–82
   PubMedGoogle Scholar